Tedesco Maureen M, Curet Myriam J
Stanford University School of Medicine, Department of Surgery, Stanford, CA 94305-5655, USA.
Expert Rev Med Devices. 2006 Jul;3(4):415-9. doi: 10.1586/17434440.3.4.415.
Laparoscopic-assisted colectomy (LAC) for colon cancer was first described in 1991. Unlike other laparoscopic procedures used to treat benign disease, the LAC for colon cancer has been slow to gain acceptance for a variety of reasons. Recently, several large, randomized controlled trials have demonstrated that LACs are comparable with open colectomies with respect to oncological issues such as survival, port-site metastases and tumor recurrence. Moreover, there are significant patient benefits with the use of LAC including duration of analgesic use, return of bowel function, length of stay and return to normal activity.
1991年首次描述了用于结肠癌的腹腔镜辅助结肠切除术(LAC)。与用于治疗良性疾病的其他腹腔镜手术不同,由于多种原因,用于结肠癌的LAC在被接受方面进展缓慢。最近,几项大型随机对照试验表明,在生存、切口种植转移和肿瘤复发等肿瘤学问题方面,LAC与开放结肠切除术相当。此外,使用LAC对患者有显著益处,包括止痛药物使用时间、肠功能恢复、住院时间和恢复正常活动情况。